We are live on
!
Find out more
BAMCO Inc Portfolio holdings
AUM
$66.6B
Turnover
22.96%
1-Year Est. Return
7.35%
This Fund
S&P 500
This Quarter
Est. Return
+12.7%
1 Year Est. Return
+7.35%
3 Year Est. Return
+62.2%
5 Year Est. Return
+84.27%
10 Year Est. Return
+776.55%
AUM
$36.9B
AUM Growth
+$2.84B
(+8.3%)
Cap. Flow
-$570M
Cap. Flow
% of AUM
-1.55%
Top 10 Holdings %
Top 10 Hldgs %
41.64%
Holding
334
New
20
Increased
130
Reduced
116
Closed
28
Avg Time Held
5.5
years
Top 10 Avg Time Held
8.4
years
Top 20 Avg Time Held
6.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Samsara
IOT
|
+$67.5M |
| 2 |
Toll Brothers
TOL
|
+$63.5M |
| 3 |
MSCI
MSCI
|
+$54.6M |
| 4 |
Eli Lilly
LLY
|
+$51.1M |
| 5 |
CoStar Group
CSGP
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$360M |
| 2 |
Ansys
ANSS
|
+$215M |
| 3 |
Alibaba
BABA
|
+$68.1M |
| 4 |
Apple
AAPL
|
+$62.3M |
| 5 |
Gartner
IT
|
+$49.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 27.54% |
| 2 | Financials | 22.33% |
| 3 | Technology | 19.5% |
| 4 | Real Estate | 9.12% |
| 5 | Healthcare | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Insulet
PODD
$9.85B
| $1.79M | ﹤0.01% |
+5,700
| New | +$1.65M |
2025 Q2
0 quarters
|
|
277
Xenon Pharmaceuticals
XENE
$3.25B
| $1.75M | ﹤0.01% |
56,000
-44,100
| -44% | -$1.44M |
2021 Q4
14 quarters
|
|
278
Teva Pharmaceutical Industries Limited
TEVA
$48B
| $1.68M | ﹤0.01% |
+100,000
| New | +$1.61M |
2025 Q2
0 quarters
|
|
279
Manchester United
MANU
$3.56B
| $1.61M | ﹤0.01% |
90,448
-21,031
| -19% | -$312K |
2013 Q2
48 quarters
|
|
280
MNTN Inc
MNTN
$774M
| $1.53M | ﹤0.01% |
+70,000
| New | +$1.61M |
2025 Q2
0 quarters
|
|
281
Novo Nordisk
NVO
$173B
| $1.48M | ﹤0.01% |
21,441
-14,221
| -40% | -$967K |
2023 Q4
6 quarters
|
|
282
Reddit
RDDT
$30.6B
| $1.46M | ﹤0.01% |
9,697
+1,487
| +18% | +$169K |
2024 Q1
5 quarters
|
|
283
Lam Research
LRCX
$336B
| $1.42M | ﹤0.01% |
14,568
+5,549
| +62% | +$440K |
2022 Q1
13 quarters
|
|
284
Natera
NTRA
$56.3B
| $1.27M | ﹤0.01% |
7,500
| – | – |
2023 Q4
6 quarters
|
|
285
Blackrock
BLK
$176B
| $1.15M | ﹤0.01% |
1,100
| – | – |
2018 Q1
29 quarters
|
|
286
Jack Henry & Associates
JKHY
$10.8B
| $1.08M | ﹤0.01% |
6,000
| – | – |
2020 Q1
21 quarters
|
|
287
Victory Capital Holdings
VCTR
$6.8B
| $1.06M | ﹤0.01% |
16,596
| – | – |
2022 Q4
10 quarters
|
|
288
Doximity
DOCS
$5.59B
| $920K | ﹤0.01% |
+15,000
| New | +$837K |
2025 Q2
0 quarters
|
|
289
Essent Group
ESNT
$5.8B
| $871K | ﹤0.01% |
14,334
| – | – |
2016 Q3
35 quarters
|
|
290
Fiserv Inc
FISV
$25.3B
| $862K | ﹤0.01% |
5,000
-8,000
| -62% | -$1.45M |
2022 Q3
11 quarters
|
|
291
Equifax
EFX
$19B
| $856K | ﹤0.01% |
3,300
+100
| +3% | +$25.4K |
2022 Q1
13 quarters
|
|
292
Coherent
COHR
$46.6B
| $821K | ﹤0.01% |
+9,202
| New | +$662K |
2025 Q2
0 quarters
|
|
293
Zoetis
ZTS
$32.7B
| $780K | ﹤0.01% |
5,000
-7,500
| -60% | -$1.19M |
2019 Q4
22 quarters
|
|
294
Home Depot
HD
$314B
| $733K | ﹤0.01% |
2,000
| – | – |
2013 Q4
46 quarters
|
|
295
CarMax
KMX
$7.69B
| $731K | ﹤0.01% |
10,875
-1,145
| -10% | -$77K |
2013 Q2
48 quarters
|
|
296
Berkshire Hathaway Class A
BRK.A
$1.13T
| $729K | ﹤0.01% |
1
| – | – |
2016 Q3
35 quarters
|
|
297
ARS Pharmaceuticals
SPRY
$390M
| $698K | ﹤0.01% |
+40,000
| New | +$577K |
2025 Q2
0 quarters
|
|
298
Qualcomm
QCOM
$189B
| $637K | ﹤0.01% |
4,000
| – | – |
2016 Q3
35 quarters
|
|
299
Goldman Sachs
GS
$261B
| $566K | ﹤0.01% |
800
| – | – |
2016 Q3
35 quarters
|
|
300
BioNTech
BNTX
$22.2B
| $562K | ﹤0.01% |
5,276
-2,399
| -31% | -$242K |
2020 Q4
18 quarters
|
|
Similar funds
BAMCO Inc's Q2 2025 Portfolio in Review
As of Q2 2025, BAMCO Inc held 334 positions worth $36.9B, up 8.3% from $34B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BAMCO Inc's Q2 2025 filing shows 20 new, 130 increased, 116 reduced and 28 closed positions. Its largest new stake was Hinge Health: 945,762 shares worth $48.9M. The largest sale was Tesla, an estimated $360M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 27% a quarter earlier, followed by Financials and Technology.
- BAMCO Inc's largest Q2 2025 buy was Hinge Health: 945,762 shares worth $48.9M.
- BAMCO Inc added most to Samsara in Q2 2025, an estimated $67.5M increase.
- BAMCO Inc's biggest Q2 2025 reduction was Tesla, cutting an estimated $360M.
- BAMCO Inc fully exited Utz Brands in Q2 2025, selling an estimated $45.8M.
- BAMCO Inc's ten largest holdings make up 42% of its $36.9B portfolio in Q2 2025.
- BAMCO Inc opened 20 new positions and closed 28 in Q2 2025.
- BAMCO Inc's portfolio value rose 8.3% quarter-over-quarter to $36.9B.
Based on BAMCO Inc's 13F filing for Q2 2025, filed 14 Aug 2025.